Recruiting Erectile Dysfunction Studies in Albany
Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen
The purpose of this study is to assess the impact of ibuprofen in men with elevated serum PSA....
A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)
This pan-tumor trial is designed as a signal-seeking trial to assess efficacy and safety of raludotatug deruxtecan (R-DXd) monotherapy in locally advanced or metastatic solid tumors with various cadhe...
About Erectile Dysfunction Clinical Trials in Albany
Erectile dysfunction is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It affects about 30 million men in the U.S. and is often a sign of underlying cardiovascular disease. Treatment includes PDE5 inhibitors, vacuum devices, and penile implants.
There are currently 2 erectile dysfunction clinical trials recruiting participants in Albany, NEW%20YORK. These studies are seeking a combined 400 participants. Research is being sponsored by University of Chicago, Daiichi Sankyo. Clinical trial participation is free and participants receive study-related medical care at no cost.
Erectile Dysfunction Clinical Trials in Albany — FAQ
Are there erectile dysfunction clinical trials in Albany?
Yes, there are 2 erectile dysfunction clinical trials currently recruiting in Albany, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Albany?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Albany research site will contact you about next steps.
Are clinical trials in Albany free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Albany studies also compensate for your time and travel.
What erectile dysfunction treatments are being tested?
The 2 active trials in Albany are testing new therapies including novel drugs, biologics, and treatment approaches for erectile dysfunction.
Data updated March 2, 2026 from ClinicalTrials.gov